---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-322704"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:51:35.571247+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# BioMarin appoints Rashmi Ramchandani as Chief Accounting Officer, effective Jan 19, 2026

## Summary
- Ramchandani becomes VP, Chief Accounting Officer and principal accounting officer; CFO Brian Mueller remains principal financial officer.
- Compensation: $460k base salary, $400k sign-on bonus, 45% target bonus, RSUs valued at $1.05M (4-year vest) and $400k (1-year cliff), options valued at $450k (4-year monthly vest).
- She previously served as VP, Global Business Controller at Gilead Sciences and VP, Controller at Strava. Background includes Deloitte, Clorox, McKesson.
- Sign-on bonus repayable if employment ends within two years for reasons other than job elimination, death, or disability.

## SEC filing metadata
- accession: 0001193125-25-322704
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/0001193125-25-322704-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/d848371d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-322704
- JSON: https://secwatch.observer/filing/0001193125-25-322704.json
- Plain text: https://secwatch.observer/filing/0001193125-25-322704.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.